Tegretol CR · DIN 00773611 · 200 mg · LA tablet
Limited Use, Reason for Use code 67 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 67 required
Write on scriptReason for Use code 67 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 67
Reason for Use code 67
For patients who have been tried on conventional carbamazepine with unsatisfactory results due to adverse effects or poor control of symptoms.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Tegretol CR · DIN 00773611
Manufacturer: Novartis Pharma Canada Inc.; listing date 1996-10-01
Health Canada: Marketed since 1999-03-10 · brand TEGRETOL CR · ATC N03AF01 CARBAMAZEPINE · form Tablet (extended-release) · route Oral · ingredients CARBAMAZEPINE 200 MG · company Novartis pharmaceuticals canada inc · schedule Prescription
Ministry pays: $0.3845 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00773611)
Source record
DIN 00773611: Tegretol CR
Raw flags: sec12=Y, sec3=Y
Item: 281200065; group id 422; item number 1045; lccId 00070; manufacturer id NOV
Source form: LA Tab; strength: 200mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $0.6161; ministry $0.3845
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00773611
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=8373
Interchangeable products
Sandoz Carbamazepine CR · DIN 02261839 · $0.3845
Shortage status: resolved shortage (ended July 18, 2024); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00773611
Shortage record checked October 6, 2026